Overview
| Alternate Names: | BTF3 homologue; basic transcription factor 3, like 1 |
|---|---|
| Alternate Symbols: | HUMBTFB; OCIF; OPG; TNFRSF11B; lambda h27A |
| PharmGKB Accession Id: | PA25446 |
Details
| Cytogenetic Location: | chr13 : q22.3 |
|---|---|
| GP mRNA Boundary†: | chr13 : 76400201 - 76400836 |
| GP Gene Boundary†: | chr13 : 76390201 - 76403836 |
| Strand: | plus |
| Product Name: | basic transcription factor 3, like 1 |
†
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped
onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries
by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for
potential regulatory regions.
Curated Information
The following diseases are in curated knowledge about this gene.
| Disease | Relationship | Evidence | |
|---|---|---|---|
|
Bone Diseases, Metabolic |
|
Publications |
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Publications |
Curated Phenotype Datasets
These datasets are sorted alphabetically by title.
- Treatment-specific changes in gene expression (top 150 discriminating genes)
- FA
Submitted by William Evans, PharmD involving ABCA2, ACAT2, ACTL6A, ALMS1, ANXA2, AP1S2, ARL4C, ATM, AZU1, BAX, BEST1, BMI1, BNIP3L, BPI, BTF3L1, BTF3L3, BYSL, C1R, C8G, CAMP, CBFA2T2, CDKN1B, CENTB2, CEP170, CHD1L, COG2, COMP, CTSG, CUL4B, CYFIP2, CYR61, DEFA1, DEFA3, DYRK1A, E2F5, EIF1AY, ELA2, FAAH, FAM175B, FOS, FZD6, G6PD, GADD45A, GNAS, GP5, GPLD1, GRM5, GSS, HAT1, HHLA1, HOXC6, IGFBP5, IGHG3, IL32, KLF11, LAPTM4B, LCN2, LILRB1, MET, MICA, MICB, MLH1, MPO, MRE11A, MUC3A, MYC, NALCN, NMT2, NR2C1, NR2C2, NRXN2, NTRK3, OLFM4, ORC2L, PBX2, PCM1, PDE6B, PIK3R3, PLS1, PMVK, POLR3C, PRF1, PRKY, PTPRG, RABL3, RALBP1, RBBP8, RBM19, RCC1, RFX4, S100A12, S100A2, S100A4, S100A8, S100A9, SEC22B, SERPING1, SERPINI2, SIM1, SLA, SLC14A2, SLC15A1, SLC1A4, SLC1A7, SMCHD1, SPOCK2, SREBF2, STAG1, STAT1, STK24, STK38, STRAP, TCEAL4, TGIF, THOC2, TOB2, TRA@, TRB@, TXK, TYROBP, UBE2G1, UCHL3, UROS, VARS, YY1, ZBTB1, ZFPL1, ZNF217, ZNF263, mercaptopurine, methotrexate, and Precursor Cell Lymphoblastic Leukemia-Lymphoma